Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01656564 · ClinicalTrials.gov registry record
Clinical Outcomes of People Who Acquired HIV in Early Life
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 177
- Enrollment target
NCT01656564: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT01656564 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 177 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01656564 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 177 participants
- Enrollment target
Study Summary
Background: \- Long-term survival with the human immunodeficiency virus (HIV) is not well understood. Adults who were infected with HIV as children have lived with the virus for many years. However, the effect of HIV on this group of people has not been studied in depth. Researchers are interested in studying how HIV infection and the medicines used to treat it affect people who were infected early in life. They want to find out if there are any problems with how HIV-infected children grow and develop as adults, especially if they have developed heart problems. As part of this study, people with HIV will be compared with healthy volunteers. Objectives: \- To study the effect of HIV infection and treatment on people who acquired HIV infection in early life. Eligibility: * Individuals at least 18 years of age who acquired HIV infection in early life. * Healthy volunteers at least 18 years of age without HIV will serve as controls Design: * Participants will be screened with a physical exam and medical history. They will have regular study visits about once a year for up to 10 years to collect health information. * Blood and urine samples will be collected to look at kidney and liver function. * X-ray scans will be used to look at bone density and the amount of fat and muscle in the body. * Treatment will not be provided as part of this study.
Primary Outcome
vital status and health outcomes will be determined annually throughout the study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2012-08-27 |
| Est. Completion | 2023-03-08 |
What the finished NCT01656564 record still lists
NCT01656564 is an observational study that tracks outcomes without assigning an intervention. The registered 177 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01656564 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01656564 about?
NCT01656564 is a clinical study titled "Clinical Outcomes of People Who Acquired HIV in Early Life". Background: \- Long-term survival with the human immunodeficiency virus (HIV) is not well understood. Adults who were infected with HIV as children have lived with the virus for many years. However, the effect of HIV on this group of people has not been studied in depth. Researchers are interested ...
What is the current status of trial NCT01656564?
This trial is currently completed. The enrollment target is 177 participants. The study started on 2012-08-27. Estimated completion is 2023-03-08.
Who is sponsoring clinical trial NCT01656564?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491551 · 177 participants · NA
Alcohol-ROC-Training
- NCT06108050 · 177 participants · Phase 1
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
- NCT06575712 · 177 participants · NA
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
- NCT06674980 · 177 participants · NA
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI